Real-World Clinical Characteristics and Treatment Patterns of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: A Nationwide Korean EGFR Registry
Year: 2026
Type: article
Study design: Observational Study
Abstract: Purpose: Despite advances in epidermal growth factor receptor (EGFR)-targeted therapy for non-small cell lung cancer (NSCLC), real-world data on diagnostic and treatment patterns across all disease stages remain limited. This study used the nationwide Korean EGFR Registry to characterize contemporary clinical practice in EGFR-mutant NSCLC. Materials and Methods: A total of 1,522 patients with pathologically confirmed EGFR-mutant NSCLC were prospectively enrolled from 40 Korean institutions (June 2022-June 2024). Data on baseline clinical and molecular characteristics, biomarker testing patterns, and treatment for all lines of therapy were collected using standardized electronic case report forms. Results: The median age of the study population was 68 years, 59.7% were female, and 64.5% were never-smokers. Stage IV disease accounted for 57.8% of cases. The predominant EGFR mutations were exon 19 deletion (48.6%) and L858R (47.1%). NGS was performed for ~23% of patients. In patients with stage IV disease, third-generation TKI use increased markedly (14.3% in 2022 vs. 91.1% in 2024). Stage III management was notably heterogeneous; definitive concurrent chemoradiotherapy was used in only 15.3% of stage III patients overall, with surgery-based treatment predominating in stage IIIA and systemic therapy accounting for all treatment in stage IIIC. The 3-year overall survival rates were 97.2%, 90.9%, 78.3%, and 58.4% for stages I-IV, respectively. Conclusion: This nationwide registry analysis reveals rapid adoption of third-generation TKIs in metastatic EGFR-mutant NSCLC and substantial heterogeneity in stage III disease management. These findings provide clinically meaningful insights into the evolving treatment paradigm of EGFR-mutant NSCLC across disease stages in routine practice.
Source: Cancer Research and Treatment
Authors: Myeong Geun Choi, Chang Dong Yeo, Seong Hoon Yoon, Eun Young Kim, Jeong Eun Lee, Shin Yup Lee, In-Jae Oh, Do Jin Kim, Jeong Seon Ryu, Jae Cheol Lee, Young-Chul Kim, Tae Won Jang, Kye Young Lee, Sung Yong Lee, Cheol-Kyu Park, Seung Hun Jang, Seung Joon Kim, for the Korean EGFR Registry Investigators
Institutions: Asan Medical Center, University of Ulsan, Catholic University of Korea, Pusan National University Yangsan Hospital, Yonsei University, Severance Hospital, Chungnam National University, Kyungpook National University, Chonnam National University, Chonnam National University Hwasun Hospital, Soonchunhyang University Hospital Bucheon, Inha University, Inha University Hospital, Kosin University, Konkuk University, Konkuk University Medical Center, Korea University Guro Hospital, Hallym University Sacred Heart Hospital, The Catholic University of Korea Seoul St. Mary's Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funder: Yuhan
OpenAlex ID: W7235900082
